Categories AlphaGraphs, Earnings, Health Care
Biogen (BIIB) Q2 2024 Earnings: Key financials and quarterly highlights
Biogen Inc. (NASDAQ: BIIB) reported its second quarter 2024 earnings results today.
Total revenue of $2.5 billion was flat at actual currency and up 1% at constant currency compared to the same period a year ago.
Net income attributable to Biogen Inc. was $583.6 million compared to $591.6 million last year.
GAAP EPS dropped 2% to $4.00 while adjusted EPS rose 31% to $5.28 compared to last year.
For the full year of 2024, the company expects total revenue to decline by a low-single digit percentage. Adjusted EPS is expected to be $15.75-16.25.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
Important takeaways from Conagra Brands’ Q3 2025 report
Conagra Brands, Inc. (NYSE: CAG) has reported weaker-than-expected revenue and profit for the February quarter, with sales declining across all business segments amid softer demand and persistent supply challenges. The
Main takeaways from Lamb Weston’s (LW) Q3 2025 earnings report
Shares of Lamb Weston Holdings, Inc. (NYSE: LW) jumped 9% on Thursday after the company delivered better-than-expected results for the third quarter of 2025 and reaffirmed its outlook for the
Summary: Tesla (TSLA) reports Q1 2025 production, deliveries
Tesla Inc. (NASDAQ: TSLA) has announced results of vehicle production and deliveries for the first quarter of 2025. The company also provided data on the deployment of energy storage products
